Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Vanesa González-Núñez, Antonio Valero & Joaquim Mullol. (2013) Safety evaluation of desloratadine in allergic rhinitis. Expert Opinion on Drug Safety 12:3, pages 445-453.
Read now
Read now
R. Ramanathan, L. Reyderman, A.-D. Su, N. Alvarez, S. K. Chowdhury, K. B. Alton, M. A. Wirth, R. P. Clement, P. Statkevich & J. E. Patrick. (2007) Disposition of desloratadine in healthy volunteers. Xenobiotica 37:7, pages 770-787.
Read now
Read now
R. Ramanathan, L. Reyderman, K. Kulmatycki, A.-D. Su, N. Alvarez, S. K. Chowdhury, K. B. Alton, M. A. Wirth, R. P. Clement, P. Statkevich & J. E. Patrick. (2007) Disposition of loratadine in healthy volunteers. Xenobiotica 37:7, pages 753-769.
Read now
Read now
Bruce Prenner, Kenneth Kim, Samir Gupta, Sauzanne Khalilieh, Bhavna Kantesaria, Prasarn Manitpisitkul, Richard Lorber, Zaiqi Wang & Barry Lutsky. (2006) Adult and paediatric poor metabolisers of desloratadine: an assessment of pharmacokinetics and safety. Expert Opinion on Drug Safety 5:2, pages 211-223.
Read now
Read now
Garry M Walsh. (2002) Emerging safety issues regarding long-term usage of H1-receptor antagonists. Expert Opinion on Drug Safety 1:3, pages 225-235.
Read now
Read now
Luis M Salmun. (2002) Antihistamines in late-phase clinical development for allergic disease. Expert Opinion on Investigational Drugs 11:2, pages 259-273.
Read now
Read now
Articles from other publishers (36)
Mariela Gomez Perez, Georgiana Tanasie, Armelle Tchoumi Neree, Narjara Gonzalez Suarez, Clara Lafortune, Joanne Paquin, Lucia Marcocci, Paola Pietrangeli, Borhane Annabi & Mircea Alexandru Mateescu. (2023) P19-derived neuronal cells express H1, H2, and H3 histamine receptors: a biopharmaceutical approach to evaluate antihistamine agents. Amino Acids 55:6, pages 821-833.
Crossref
Crossref
Margot Morin-Dewaele, Sophie Bartier, François Berry, Rozenn Brillet, Dennis Salomón López-Molina, Công Trung Nguyễn, Pascale Maille, Kevin Sereno, Quentin Nevers, Laurent Softic, Jean-Marie Vaugeois, Bruno Louis, Emilie Bequignon, Patrice Bruscella, André Coste, Jean-Michel Pawlotsky, Stéphane Jamain & Abdelhakim Ahmed-Belkacem. (2022) Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry. Scientific Reports 12:1.
Crossref
Crossref
Popat Kumbhar, Kapil Kole, Tejashree Yadav, Ashwini Bhavar, Pramod Waghmare, Rajdeep Bhokare, Arehalli Manjappa, Niraj Kumar Jha, Dinesh Kumar Chellappan, Sunita Shinde, Sachin Kumar Singh, Kamal Dua, Ahmad Salawi, John Disouza & Vandana Patravale. (2022) Drug repurposing: An emerging strategy in alleviating skin cancer. European Journal of Pharmacology 926, pages 175031.
Crossref
Crossref
H. J. Weng & T. F. Tsai. (2021) ABCB1 in dermatology: roles in skin diseases and their treatment. Journal of Molecular Medicine 99:11, pages 1527-1538.
Crossref
Crossref
Yajing Hou, Shuai Ge, Xiaowei Li, Cheng Wang, Huaizhen He & Langchong He. (2021) Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis. Chemico-Biological Interactions 338, pages 109420.
Crossref
Crossref
Suguru Kato, Abhi Shah, Mihaela Plesescu, Yoshinari Miyata, Jayaprakasam Bolleddula, Swapan Chowdhury & Xiaochun Zhu. (2020) Prediction of Human Disproportionate and Biliary Excreted Metabolites Using Chimeric Mice with Humanized Liver. Drug Metabolism and Disposition 48:10, pages 934-943.
Crossref
Crossref
Yasmin Schmid, Alexander Navarini, Zita-Rose Manjaly Thomas, Bettina Pfleiderer, Stephan Krähenbühl & Simon M Mueller. (2019) Sex differences in the pharmacology of itch therapies—a narrative review. Current Opinion in Pharmacology 46, pages 122-142.
Crossref
Crossref
Selvakumar Kanthiah & Valliappan Kannappan. (2017) D-Optimal mixture design optimization of an HPLC method for simultaneous determination of commonly used antihistaminic parent molecules and their active metabolites in human serum and urine. Biomedical Chromatography 31:8, pages e3932.
Crossref
Crossref
Piotr Kuna, Dariusz Jurkiewicz, Magdalena M. Czarnecka-Operacz, Rafał Pawliczak, Jarosław Woroń, Marcin Moniuszko & Andrzej Emeryk. (2017) The role and choice criteria of antihistamines in allergy management – Expert opinion. Alergologia Polska - Polish Journal of Allergology 4:1, pages 7-19.
Crossref
Crossref
Ruben Vardanyan. 2017. Piperidine-Based Drug Discovery. Piperidine-Based Drug Discovery
223
239
.
Ting Wang, Kun Zhang, Tingting Li, Lin He, Huiru Xie, Xuehua Jiang & Ling Wang. (2015) Prevalence of Desloratadine Slow-metabolizer Phenotype and Food-dependent Pharmacokinetics of Desloratadine in Healthy Chinese Volunteers. Clinical Drug Investigation 35:12, pages 807-813.
Crossref
Crossref
Rafał Pawliczak. (2015) Alergiczny nieżyt nosa – nowoczesne leczenie w świetle wytycznych. Alergologia Polska - Polish Journal of Allergology 2:3, pages 106-110.
Crossref
Crossref
G. Walter Canonica & Michael Blaiss. (2011) Antihistaminic, Anti-Inflammatory, and Antiallergic Properties of the Nonsedating Second-Generation Antihistamine Desloratadine: a Review of the Evidence. World Allergy Organization Journal 4:2, pages 47-53.
Crossref
Crossref
Evrim Alyamac Dizdar, Bulent Enis Sekerel & Ayfer Tuncer. (2008) Desloratadine: a review of pharmacology and clinical efficacy in allergic rhinitis and urticaria. Therapy 5:6, pages 817-828.
Crossref
Crossref
Shigeru Hishinuma, Yuko Sato, Yusuke Kobayashi, Hiroshi Komazaki & Masaki Saito. (2008) Intact Cell Binding for In Vitro Prediction of Sedative and Non-sedative Histamine H1–Receptor Antagonists Based on Receptor Internalization. Journal of Pharmacological Sciences 107:1, pages 66-79.
Crossref
Crossref
A. M. Moustafa & A. S. Girgis. (2007) Synthesis and crystal structure determination of 6,7-dihydro-2-methoxy-4-(substituted)-5H -benzo[6,7]cyclohepta[1,2-b ]pyridine-3-carbonitrile. Crystal Research and Technology 42:4, pages 400-406.
Crossref
Crossref
Ramón Pérez. (2005) Acute cholestasis related to desloratidine. World Journal of Gastroenterology 11:23, pages 3647.
Crossref
Crossref
Glenis Scadding. (2005) Predicting and Establishing the Clinical Efficacy of a Histamine H1-Receptor Antagonist. Clinical Drug Investigation 25:3, pages 153-164.
Crossref
Crossref
Michael M. Cyr, Lisa M. Hayes, Lynn Crawford, Adrian J. Baatjes, Paul K. Keith & Judah A. Denburg. (2005) The Effect of Desloratadine on Eosinophil/Basophil Progenitors and Other Inflammatory Markers in Seasonal Allergic Rhinitis: A Placebo-Controlled Randomized Study. International Archives of Allergy and Immunology 138:3, pages 209-216.
Crossref
Crossref
D. K. Agrawal. (2004) Anti-inflammatory properties of desloratadine. Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy 34:9, pages 1342-1348.
Crossref
Crossref
M. Molimard, B. Diquet & M. Strolin Benedetti. (2004) Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundamental and Clinical Pharmacology 18:4, pages 399-411.
Crossref
Crossref
Ashok Purohit, Michel Melac, Gabrielle Pauli & Nelly Frossard. (2004) Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours. Annals of Allergy, Asthma & Immunology 92:6, pages 635-640.
Crossref
Crossref
U. Satish, S. Streufert, M. Dewan & S. Vande Voort. (2004) Improvements in simulated real-world relevant performance for patients with seasonal allergic rhinitis: impact of desloratadine. Allergy 59:4, pages 415-420.
Crossref
Crossref
William E Berger. (2004) Allergic Rhinitis in Children. Pediatric Drugs 6:4, pages 233-250.
Crossref
Crossref
Michael W. Sinz. 2004. Applications of Pharmacokinetic Principles in Drug Development. Applications of Pharmacokinetic Principles in Drug Development
75
132
.
Ashok Purohit, Michel Melac, Gabrielle Pauli & Nelly Frossard. (2003) Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin. British Journal of Clinical Pharmacology 56:4, pages 388-394.
Crossref
Crossref
Jeffrey A. Wilken, Robert L. Kane, Anne K. Ellis, Elizabeth Rafeiro, Maureen P. Briscoe, Cynthia L. Sullivan & James H. Day. (2003) A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis. Annals of Allergy, Asthma & Immunology 91:4, pages 375-385.
Crossref
Crossref
Joseph W. Polli, Todd M. Baughman, Joan E. Humphreys, Kelly H. Jordan, Angela L. Mote, Jo A. Salisbury, Timothy K. Tippin & Cosette J. Serabjit‐Singh. (2003) P‐glycoprotein Influences the Brain Concentrations of Cetirizine (Zyrtec®), a Second‐Generation Non‐Sedating Antihistamine. Journal of Pharmaceutical Sciences 92:10, pages 2082-2089.
Crossref
Crossref
Usha Satish & Siegfried Streufert. (2007) Treatment of Hay Fever With the Antihistamine Desloratadine: Impact on Performance of Simple, Intermediate, and Complex Task Requirements1. Journal of Applied Biobehavioral Research 8:2, pages 61-76.
Crossref
Crossref
Daniel K. C. Lee, Kay Haggart, Graeme P. Currie, Sandra D. Anderson & Brian J. Lipworth. (2003) The effects of histamine and leukotriene receptor antagonism on nasal mannitol challenge in allergic rhinitis. British Journal of Clinical Pharmacology 55:6, pages 639-642.
Crossref
Crossref
Daniel K.C. Lee, Caroline E. Bates, Graeme P. Currie & Brian J. Lipworth. (2003) Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma. Journal of Allergy and Clinical Immunology 111:2, pages 337-341.
Crossref
Crossref
William E. Berger, Eric J. Schenkel & Lyndon E. Mansfield. (2002) Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Annals of Allergy, Asthma & Immunology 89:5, pages 485-491.
Crossref
Crossref
Patrick Bernardelli, Bernard Gaudillière & Fabrice Vergne. 2002. Annual Reports in Medicinal Chemistry Volume 37. Annual Reports in Medicinal Chemistry Volume 37
257
277
.
R. Lorber, L. M. Salmun & M. R. Danzig. 2002. New Trends in Allergy V. New Trends in Allergy V
252
259
.
W. Kreutner, J. A. Hey, J. C. Anthes & A. Barnett. 2002. New Trends in Allergy V. New Trends in Allergy V
241
251
.
A. Gauger, R. Hein, G. Rikken, H. Staudinger & J. Ring. 2002. New Trends in Allergy V. New Trends in Allergy V
233
240
.